- Home
- BATL vs ASBP Comparison
BATL vs ASBP Comparison
Compare BATL & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BATL | ASBP |
|---|---|---|
| Founded | 1987 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.1M | 18.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BATL | ASBP |
|---|---|---|
| Price | $1.19 | $0.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 79.3K | ★ 56.6M |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $183,422,000.00 | $1,941.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.00 | $0.07 |
| 52 Week High | $3.67 | $15.80 |
Technical Indicators
Market Signals| Indicator | BATL | ASBP |
|---|---|---|
| Relative Strength Index (RSI) | 47.28 | 33.53 |
| Support Level | $1.15 | $0.07 |
| Resistance Level | $1.25 | $0.10 |
| Average True Range (ATR) | 0.05 | 0.01 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 27.60 | 55.40 |
Price Performance
Historical ComparisonAbout BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.
About ASBP Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.